Evidence map›Paper›PMID 31557793›Full record

ReviewInternational journal of molecular sciences2019

Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models.

Andrea Baehr, Nikolai Klymiuk, Christian Kupatt

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Assessment of Mitochondrial Function and Oxygen Consumption Measured DuringTransplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
  10. Molecular Network Approach RevealsInternational journal of molecular sciences · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrea BaehrKlinikum Rechts der Isar, Internal Medicine I, Technical University of Munich, 81675 Munich, Germany. a.baehr@tum.de.
Nikolai KlymiukKlinikum Rechts der Isar, Internal Medicine I, Technical University of Munich, 81675 Munich, Germany. n.klymiuk@tum.de.
Christian KupattKlinikum Rechts der Isar, Internal Medicine I, Technical University of Munich, 81675 Munich, Germany. christian.kupatt@tum.de.

Funding

Deutsche Forschungsgemeinschaft TRR127Deutsches Zentrum für Herz-Kreislaufforschung Large Animal Platform
6 · The paper itself

Abstract

Coronary heart diseases are of high relevance for health care systems in developed countries regarding patient numbers and costs. Disappointingly, the enormous effort put into the development of innovative therapies and the high numbers of clinical studies conducted are counteracted by the low numbers of therapies that become clinically effective. Evidently, pre-clinical research in its present form does not appear informative of the performance of treatments in the clinic and, even more relevant, it appears that there is hardly any consent about how to improve the predictive capacity of pre-clinical experiments. According to the steadily increasing relevance that pig models have gained in biomedical research in the recent past, we anticipate that research in pigs can be highly predictive for ischemia-reperfusion injury (IRI) therapies as well. Thus, we here describe the significance of pig models in IRI, give an overview about recent developments in evaluating such models by clinically relevant methods and present the latest insight into therapies applied to pigs under IRI.

Indexed as

BiomarkersDisease SusceptibilityAnimalsBiomimeticsDisease Models, AnimalDrug DiscoveryDrug Evaluation, PreclinicalNitric OxideReperfusion InjurySwineBiomarkersNitric Oxidecardiovascular animal modelI/R injuryischemia reperfusionpig modelpreclinical research

Identifiers

PMID31557793
PMCPMC6801853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.